GALLSTONE DISEASE IS NOT ASSOCIATED WITH LIVER FIBROSIS AND NONALCOHOLIC STEATOHEPATITIS IN NONALCOHOLIC FATTY LIVER DISEASE

被引：0
|
作者：
Yilmaz, Y. [1 ,2 ]
Ayyildiz, T. [3 ]
Akin, H. [1 ,2 ]
Colak, Y. [4 ]
Ozturk, O. [4 ]
Senates, E. [5 ]
Tuncer, I. [4 ]
Dolar, E. [3 ]
机构：
[1] Marmara Univ, Sch Med, Dept Gastroenterol, Istanbul, Turkey
[2] Marmara Univ, Inst Gastroenterol, Istanbul, Turkey
[3] Uludag Univ, Sch Med, Dept Gastroenterol, Bursa, Turkey
[4] Istanbul Medeniyet Univ, Fac Med, Dept Gastroenterol, Istanbul, Turkey
[5] Dicle Univ, Sch Med, Dept Gastroenterol, Diyarbakir, Turkey
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)61375-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1376
引用
收藏
页码：S553 / S554
页数：2
相关论文
共 50 条
  • [41] The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis
    Buchman, Alan L.
    Naini, Bita V.
    Spilker, Bert
    SEMINARS IN LIVER DISEASE, 2017, 37 (01) : 33 - 44
  • [42] Prevalence of nonalcoholic steatohepatitis and advanced fibrosis in adolescents with nonalcoholic fatty liver disease in the United States
    Selvakumar, Praveen Kumar Conjeevaram
    Kabbany, Mohammad Nasser
    Rifai, Ghassoub
    Rocio, Lopez
    Nobili, Valerio
    Alkhouri, Naim
    HEPATOLOGY, 2016, 64 : 106A - 106A
  • [43] Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity
    Fracanzani, Anna Ludovica
    Valenti, Luca
    Bugianesi, Elisabetta
    Vanni, Ester
    Grieco, Antonio
    Miele, Luca
    Consonni, Dario
    Fatta, Erika
    Lombardi, Rosa
    Marchesini, Giulio
    Fargion, Silvia
    JOURNAL OF HEPATOLOGY, 2011, 54 (06) : 1244 - 1249
  • [44] Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease
    Kim, Donghee
    Kim, Won
    Joo, Sae Kyung
    Kim, Jung Ho
    Harrison, Stephen A.
    Younossi, Zobair M.
    Ahmed, Aijaz
    LIVER INTERNATIONAL, 2019, 39 (02) : 332 - 341
  • [45] Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi
    Keiichiro Sugimoto
    Hiroshi Inui
    Toshio Fukusato
    World Journal of Gastroenterology, 2015, 21 (13) : 3777 - 3785
  • [46] Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
    Radwan, Mohamed M.
    Radwan, Basil M.
    Nandipati, Kalyana C.
    Hunter, William J., III
    Agrawal, Devendra K.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (08) : 727 - 738
  • [47] The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Shouhed, Daniel
    Steggerda, Justin
    Burch, Miguel
    Noureddin, Mazen
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (09) : 797 - 811
  • [48] Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Beaton, Melanie D.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 26 (06) : 353 - 357
  • [49] Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Shan, Guan-Yue
    Wan, Hui
    Zhang, Yu-Xin
    Cheng, Jun-Ya
    Qiao, Duan-Rui
    Liu, Yi-Ying
    Shi, Wen-Na
    Li, Hai-Jun
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (10)
  • [50] The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Cha J.-Y.
    Kim D.-H.
    Chun K.-H.
    Laboratory Animal Research, 2018, 34 (4) : 133 - 139
12345